Evaluation of a New Care Model in Family Medicine Groups to Improve Medication and Support for Seniors with Major Neurocognitive Disorder
Led by CHU de Quebec-Universite Laval · Updated on 2024-08-22
400
Participants Needed
2
Research Sites
74 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a new model of care called the GPS project, designed to improve medication management and support autonomy for seniors with major neurocognitive disorder MCND or those undergoing cognitive assessment at home. The study aims to reduce the number of medications taken, avoid inappropriate prescriptions, and lessen the treatment burden while maintaining cognitive health and quality of life. This project also seeks to enhance satisfaction among seniors, their families, and healthcare professionals involved in their care.
The GPS intervention involves nurses, doctors, pharmacists, and home care teams working together in Family Medicine Groups FMGs. Pharmacists conduct interviews with seniors and their caregivers to review medications thoroughly, reconcile prescriptions using reliable sources, and develop personalized care plans in collaboration with the healthcare team. About 200 seniors in FMGs receiving the GPS intervention will be compared to another 200 seniors receiving usual care in FMGs not using the GPS model. The study includes a 12-month recruitment period and approximately 6 months of follow-up for each participant.
Participants will have their prescribed medications reviewed at the start, 3 months, and 6 months after joining the study to measure changes. Researchers will also assess changes in treatment burden from the start to the 6-month follow-up. The study involves no new drugs or devices but focuses on clinical interventions by pharmacists. Regular evaluations and follow-ups help monitor medication management, with the total participation time lasting about 6 months after enrollment.
CONDITIONS
Brief Title
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
Research Team
L
Line Guénette, Ph.D
E
Edeltraut Kröger, Ph.D
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Undergoing cognitive evaluation OR referred to a memory clinic OR diagnosed with cognitive impairment within the last year OR having major neurocognitive disorder and followed at home
Referred to the pharmacist in Family Medicine Groups exposed to the GPS intervention
Taking prescription medications
You will not qualify if you...
Receiving palliative care
Unable to answer questionnaires in French and without a caregiver
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Treatment
Duration - Up to 6 months
Participants in Family Medicine Groups exposed to the GPS intervention receive pharmacist-led medication reviews and care planning to optimize their pharmacotherapy and support autonomy.
Initial pharmacist interview and follow-up visits as needed during the 6 months
Follow-up
Duration - 6 months
Participants are monitored for changes in medication usage and treatment burden after the GPS intervention or usual care.
Visits at baseline, 3 months, and 6 months for assessments
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Similar Trials
Pilot Study of a 12-Week Exergaming Program to Improve Activity, Sleep, and Well-being in People With Major Neurocognitive Disorders in Long-Term Care
Evaluation of a New Care Model in Family Medicine Groups to Improve Medication and Support for Seniors with Major Neurocognitive Disorder
Validation of Italian Functional and Behavioral Scales for Older Adults with Memory and Cognitive Concerns
Including Subjective Cognitive Decline, Mild Cognitive Impairment, and Mild Dementia
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Reorganizing Pharmaceutical Care in Family Medicine Groups for Older Adults With or at Risk of Major Neurocognitive Disorders: Protocol for a Mixed Methods Study.